CVS Health Reports Q4 Beat but Maintains Full-Year Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 10 2026
0mins
Should l Buy CVS?
Source: seekingalpha
- Strong Earnings Performance: CVS Health's Q4 2025 revenue grew approximately 8% year-over-year to $105.7 billion, exceeding market expectations by $2.1 billion, although adjusted EPS fell about 8% to $1.09, still beating forecasts by $0.09, indicating robust overall business performance.
- Growth in Health Insurance Segment: Revenue from CVS's Health Care Benefits segment rose about 10% year-over-year to $36.3 billion, with a medical benefit ratio steady at 94.8%, reflecting improvements in government health plans and demonstrating the company's sustained competitiveness in the health insurance market.
- Pharmacy & Consumer Wellness Growth: This segment recorded $37.7 billion in revenue during the period, indicating approximately 12% year-over-year growth, with prescriptions filled increasing by 6.3% on a 30-day equivalent basis, showcasing strong consumer demand that further propelled overall revenue growth.
- Declining Profitability: Despite CVS's diluted EPS rising approximately 77% year-over-year to $2.30, primarily due to a $1.9 billion tax benefit, its gross margin fell by 50 basis points to 5.2%, indicating challenges in cost control, necessitating attention to the recovery of profitability in the future.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CVS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CVS
Wall Street analysts forecast CVS stock price to rise
17 Analyst Rating
16 Buy
1 Hold
0 Sell
Strong Buy
Current: 76.070
Low
91.00
Averages
96.71
High
105.00
Current: 76.070
Low
91.00
Averages
96.71
High
105.00
About CVS
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Volatility Intensifies: On Thursday, the Dow plunged over 500 points as Iran's new Supreme Leader announced the Strait of Hormuz would remain closed, causing Brent crude to briefly exceed $100 per barrel and West Texas Intermediate to hover around $90, leading to a bearish market sentiment as investors refrained from buying amid rising oil prices.
- Linde Stock Rises: Linde's shares increased as investors see the company benefiting from potential helium shortages linked to the Iran conflict, with Linde stating that the Middle East turmoil is neutral to net positive, allowing for price increases amid supply constraints, highlighting its strong market position.
- Corning Shares Decline: Despite Bank of America raising Corning's price target from $120 to $144, the stock fell 2%, as analysts revealed that the scale-out opportunities in data centers are much larger than previously thought, indicating a disconnect between market perception and underlying value, with Jim emphasizing its importance in their portfolio.
- Rapid Stock Review: Stocks mentioned in Wednesday's rapid review included Dicks Sporting Goods, Dollar General, and CVS Health, with Jim Cramer's charitable trust holding positions in Linde, Q, and Corning, reflecting ongoing confidence in these companies amidst market fluctuations.
See More
- Morgan Stanley Bullish on Alibaba: Morgan Stanley upgrades Alibaba to a top pick, emphasizing that owning in-house chips significantly enhances its chances of becoming an AI leader, despite facing near-term earnings pressure, the long-term outlook remains positive.
- Wells Fargo Double Upgrades Occidental: Wells Fargo upgrades Occidental from underweight to overweight with a $69 target price, citing its peer-leading capital efficiency trends in the Permian as a significant opportunity, albeit with associated risks.
- Citi Maintains Buy on Delta Air: Citigroup reaffirms its buy rating on Delta Air and issues a positive 30-day catalyst watch, believing that recent macro shocks and fuel price volatility have been largely priced into airline stocks with minimal fuel exposure.
- UBS Upgrades Aptiv to Buy: UBS raises Aptiv's rating from hold to buy, anticipating that the upcoming Versigent spin-off will unlock substantial value, setting a target price of $97.
See More
- Hilda Applbaum's Passion: Hilda Applbaum, a resident of Oakland, California, takes great pride in her blueberry bushes.
- Gardening Joy: She enjoys the process of planting seedlings, nurturing their growth, and harvesting the berries for her morning yogurt.
See More
Settlement Announcement: The Department of Justice has reached a $117.7 million settlement with Aetna, the insurance arm of CVS Health.
Allegations: The settlement stems from allegations that Aetna submitted inaccurate and untruthful diagnosis codes to inflate payments from the federal Medicare program.
See More
- Market Conditions: Crude prices are rising while stock prices are falling, creating uncertainty for investors.
- Investment Strategy: Dividend stocks are suggested as a potential safe haven for investors looking to navigate the current market volatility.
See More
- Crude Prices and Market Impact: Crude prices are rising significantly, leading to a decline in stock values, prompting investors to seek safer investment options.
- Stock Sensitivity to Oil Shocks: Not all stocks react the same way to fluctuations in oil prices, indicating that some may offer more stability during these market changes.
See More











